Search - tctmd.com

Displaying 981 - 1000 of 1053

Sort: Relevancy | Date

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

News Conference News TCT 2012

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

Presentation TCT 2012

Novel Device-Based Therapies for Advanced Heart Failure

Presenter: Daniel Burkhoff

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

Presentation TCT 2012

Novel Transapical Left Ventricular Access and Closure Devices

Presenter: Martin Leon

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

Presentation TCT 2012

A Novel Self-Expanding TAVR System: CENTERA

Presenter: Karl-Heinz Kuck

October 24, 2012

Presentation TCT 2012

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

Presenter: Jian Ye

October 24, 2012

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

Presenter: Anson Cheung

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

News Conference News TCT 2012

Registries Show Low Complication Rates With New Heart Valves

October 23, 2012

News Conference News TCT 2012

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

October 23, 2012

News Conference News TCT 2012

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

October 23, 2012

Presentation TCT 2012

What Can We Learn from Novel CTO Models?

Presenter: Greg Kaluza

October 22, 2012

Advertisement

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

Novel Devices Provide Options for LAA Therapy

Novel Device-Based Therapies for Advanced Heart Failure

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Experts Discuss Future of Renal Denervation

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Novel Transapical Left Ventricular Access and Closure Devices

Mesh-Covered Stent Shines in MASTER Trial

A Novel Self-Expanding TAVR System: CENTERA

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

Registries Show Low Complication Rates With New Heart Valves

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

What Can We Learn from Novel CTO Models?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content